Paolo Patri
Chief Executive Officer bei Medirio AG
Vermögen: 3 Mio $ am 31.03.2024
Profil
Derzeit ist Paolo Patri Chief Technology Officer der Stevanato Group SpA. In der Vergangenheit hatte Herr Patri die Position des Chief Executive Officer & Director bei ACE BioSciences A, Head-Corporate Drug Development bei CHIESI Farmaceutici SpA und Director bei Zymenex A inne.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.03.2024 | 92 288 ( 0,04% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Paolo Patri
| Unternehmen | Position | Beginn |
|---|---|---|
Medirio AG
 Medirio AG Electronic Equipment/InstrumentsElectronic Technology Medirio SA engages in the research and trading in as well as development, registration, and production of medical products. The company was founded by Giuseppe Irio Calasso in 2013 and is headquartered in Visp, Switzerland. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Paolo Patri
| Unternehmen | Position | Ende |
|---|---|---|
| STEVANATO GROUP S.P.A. | Chief Tech/Sci/R&D Officer | 29.02.2024 |
ACE BioSciences ApS
 ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark. | Chief Executive Officer | 15.07.2017 |
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Corporate Officer/Principal | 01.01.2017 |
Dompe Farmaceutici SpA
 Dompe Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Dompe Farmaceutici SpA operates as a biopharmaceutical company. It develops pharmaceutical and biotechnological drugs. The firm provides updating and scientific assistance services to doctors of general medicine, paediatrics, pneumology, otology, orthopaedics, rheumatology, physiatrist, odontology, accident and emergency and first aid stations. The company was founded by Franco Dompé in 1940 and is headquartered in Milan, Italy. | Corporate Officer/Principal | - |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Director/Board Member | - |
Ausbildung von Paolo Patri
| University of Milan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| STEVANATO GROUP S.P.A. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Health Technology |
Dompe Farmaceutici SpA
Dompe Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Dompe Farmaceutici SpA operates as a biopharmaceutical company. It develops pharmaceutical and biotechnological drugs. The firm provides updating and scientific assistance services to doctors of general medicine, paediatrics, pneumology, otology, orthopaedics, rheumatology, physiatrist, odontology, accident and emergency and first aid stations. The company was founded by Franco Dompé in 1940 and is headquartered in Milan, Italy. | Health Technology |
ACE BioSciences ApS
ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark. | Health Technology |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Health Technology |
Medirio AG
Medirio AG Electronic Equipment/InstrumentsElectronic Technology Medirio SA engages in the research and trading in as well as development, registration, and production of medical products. The company was founded by Giuseppe Irio Calasso in 2013 and is headquartered in Visp, Switzerland. | Electronic Technology |
